Stem Cells Research Today is a free monthly online journal that collates and summarizes the latest research about Stem Cells, including details on research, transplants, therapy, benefits.

Enhanced purification of cell-permeant Cre and germline transmission after transduction into mouse embryonic stem cells.

Peitz M, Jäger R, Patsch C, Jäger A, Egert A, Schorle H, Edenhofer F

Stem Cell Engineering Group, Institute of Reconstructive Neurobiology, Life & Brain Center and Hertie Foundation, University of Bonn, Bonn, Germany.

Continuous expression of Cre recombinase has the potential to yield toxic side effects in various cell types, thereby limiting applications of the Cre/loxP system for conditional mutagenesis. In this study, we investigate the potential of Cre protein transduction to overcome this limitation. COS-7, CV1-5B, and mouse embryonic stem (ES) cells treated with cell-permeant Cre (HTNCre) maintain a normal growth behavior employing Cre concentrations sufficient to induce recombination in more than 90% of the cells, whereas continuous application of high doses resulted in markedly reduced proliferation. HTNCre-treated ES cells maintain a normal karyotype and are still able to contribute to the germline. Moreover, we present an enhanced HTNCre purification protocol that allows the preparation of a concentrated glycerol stock solution, thereby enabling a considerable simplification of the Cre protein transduction procedure. The protocol described here allows rapid and highly efficient conditional mutagenesis of cultured cells. genesis 45:508-517, 2007. (c) 2007 Wiley-Liss, Inc.

Published 2 August 2007 in Genesis, 45(8): 508-17.
Full-text of this article is available online (may require subscription).

© 2004-2008 Stem Cells Research Today. All Rights Reserved.